Rapid affordable aptamer-based diagnostic test for hepatitis C virus

Ended Project Grant Awarded Last action

Award ID
R43PS005315
Recipient
Awarding agency
Obligated
$1,002,400

Award facts

Completion date
Funding agency
Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Alachua, FL, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services Centers for Disease Control and Prevention awarded $1.0024 million to Aptus Biosciences LLC on September 30, 2025, under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084) to develop a rapid, affordable aptamer-based diagnostic test for Hepatitis C virus. Work is performed in Alachua, Florida through September 29, 2026. Aptus Biosciences, a minority-owned small business and self-certified small disadvantaged business based in Gainesville, Florida, specializes in advanced diagnostic research using aptamer-based technologies. The company leverages sophisticated molecular diagnostic techniques to create highly sensitive and specific diagnostic reagents, with this project addressing rapid detection and improved early management of Hepatitis C infection.

Transactions

Action Obligated Date
Amendment $0
Amendment $501,200
Original award $501,200

Quick answers

Who received award R43PS005315?

R43PS005315 was awarded to Aptus Biosciences LLC by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2025.

How much is award R43PS005315 worth?

$1,002,400 has been obligated on R43PS005315.

Which agency awarded R43PS005315?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43PS005315, with funding from Office of the Director (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award